IS7217A - Leysnistýrðar fjölliðasamsetningar af beinvaxtamótunar efnasamböndum - Google Patents

Leysnistýrðar fjölliðasamsetningar af beinvaxtamótunar efnasamböndum

Info

Publication number
IS7217A
IS7217A IS7217A IS7217A IS7217A IS 7217 A IS7217 A IS 7217A IS 7217 A IS7217 A IS 7217A IS 7217 A IS7217 A IS 7217A IS 7217 A IS7217 A IS 7217A
Authority
IS
Iceland
Prior art keywords
solvent
polymer compositions
bone growth
modifying compounds
controlled polymer
Prior art date
Application number
IS7217A
Other languages
English (en)
Inventor
Dumont Francis
Wilker Korsmeyer Richard
Li Mei
Madhav Paralkar Vishwas
Lee Dunn Richard
Alexander Jeffers Scott
Zhou Mingxing
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of IS7217A publication Critical patent/IS7217A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
IS7217A 2001-11-30 2004-04-07 Leysnistýrðar fjölliðasamsetningar af beinvaxtamótunar efnasamböndum IS7217A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33725501P 2001-11-30 2001-11-30
PCT/IB2002/004965 WO2003045351A1 (en) 2001-11-30 2002-11-20 Controlled release polymeric compositions of bone growth promoting compounds

Publications (1)

Publication Number Publication Date
IS7217A true IS7217A (is) 2004-04-07

Family

ID=23319774

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7217A IS7217A (is) 2001-11-30 2004-04-07 Leysnistýrðar fjölliðasamsetningar af beinvaxtamótunar efnasamböndum

Country Status (34)

Country Link
US (2) US20030104031A1 (is)
EP (1) EP1448166A1 (is)
JP (1) JP4903985B2 (is)
KR (1) KR100629380B1 (is)
CN (1) CN1599598A (is)
AP (1) AP1781A (is)
AR (1) AR037462A1 (is)
AU (2) AU2002347502A1 (is)
BR (1) BR0214610A (is)
CA (1) CA2468703C (is)
DO (1) DOP2002000534A (is)
EA (1) EA011350B1 (is)
EC (1) ECSP045124A (is)
GE (1) GEP20063951B (is)
GT (1) GT200200242A (is)
HR (1) HRP20040486A2 (is)
HU (1) HUP0402135A3 (is)
IL (1) IL161835A0 (is)
IS (1) IS7217A (is)
MA (1) MA27084A1 (is)
MX (1) MXPA04003723A (is)
NO (1) NO20042273L (is)
NZ (1) NZ533115A (is)
OA (1) OA12731A (is)
PA (1) PA8559001A1 (is)
PE (1) PE20030581A1 (is)
PL (1) PL370085A1 (is)
SV (1) SV2004001421A (is)
TN (1) TNSN04096A1 (is)
TW (1) TW200300695A (is)
UA (1) UA76792C2 (is)
WO (1) WO2003045351A1 (is)
YU (1) YU35004A (is)
ZA (1) ZA200402755B (is)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074425B2 (en) * 2002-09-26 2006-07-11 Bonewax, Llc Hemostatic compositions and methods
WO2004071356A2 (en) * 2003-02-10 2004-08-26 Smith & Nephew, Inc. Resorbable devices
GB0307011D0 (en) 2003-03-27 2003-04-30 Regentec Ltd Porous matrix
CN1909911A (zh) * 2003-10-01 2007-02-07 浩鼎生技公司 通过给予氨基糖治疗哺乳动物的疾病状态及其用途
GB0329654D0 (en) 2003-12-23 2004-01-28 Smith & Nephew Tunable segmented polyacetal
US8123787B2 (en) 2004-10-28 2012-02-28 Ogilvie James W Method of treating scoliosis using a biological implant
US8641738B1 (en) 2004-10-28 2014-02-04 James W. Ogilvie Method of treating scoliosis using a biological implant
JP2009504929A (ja) * 2005-08-18 2009-02-05 スミス アンド ネフュー ピーエルシー 高強度デバイス及び複合材料
CN100443065C (zh) * 2006-01-26 2008-12-17 上海交通大学 用于颌面骨缺损修复的复合体系植入体单元
EP2120745B1 (en) 2006-11-30 2010-12-29 Smith & Nephew, Inc. Fiber reinforced composite material
EP2142353A1 (en) 2007-04-18 2010-01-13 Smith & Nephew PLC Expansion moulding of shape memory polymers
WO2008131197A1 (en) 2007-04-19 2008-10-30 Smith & Nephew, Inc. Multi-modal shape memory polymers
AU2008243035B2 (en) 2007-04-19 2013-09-12 Smith & Nephew, Inc. Graft fixation
US8062739B2 (en) * 2007-08-31 2011-11-22 Zimmer, Inc. Hydrogels with gradient
US20090181068A1 (en) * 2008-01-14 2009-07-16 Dunn Richard L Low Viscosity Liquid Polymeric Delivery System
EP2172189A1 (en) * 2008-10-01 2010-04-07 Novartis AG Pharmaceutical Compositions
PL2323623T3 (pl) 2008-08-12 2017-04-28 Novartis Ag Kompozycje farmaceutyczne
US20100130959A1 (en) * 2008-10-15 2010-05-27 Palmetto Biomedical, Inc. Device and method for delivery of therapeutic agents via artificial internal implants
US9642658B2 (en) 2008-10-15 2017-05-09 Orthoclip Llc Device and method for delivery of therapeutic agents via internal implants
BR112012002341A8 (pt) 2009-08-06 2017-10-10 Koninklijke Philips Electronics Nv Semente radioativa para uso na terapia oncológica e método de terapia oncológica
AU2013201121A1 (en) 2011-09-20 2013-04-04 Vical Incorporated Synergistic anti-tumor efficacy using alloantigen combination immunotherapy
CN104189954B (zh) * 2014-09-19 2017-03-29 中国科学院长春应用化学研究所 一种原位固化组织工程支架及其制备方法
RU2571548C1 (ru) * 2014-12-17 2015-12-20 Федеральное государственное бюджетное учреждение науки Институт органической и физической химии им. А.Е. Арбузова Казанского научного центра Российской академии наук Ветеринарное имплантируемое средство пролонгированного действия (варианты)
SG11201804037XA (en) 2015-11-16 2018-06-28 Evonik Roehm Gmbh Injection solution comprising a non-nucleoside reverse-transcriptase inhibitor and poly(lactide-co-glycolide)
CN109498852B (zh) * 2018-12-29 2022-06-24 广州噢斯荣医药技术有限公司 治疗骨科疾病的生物降解材料及其应用
JP2023500506A (ja) 2019-11-04 2023-01-06 アストラゼネカ・アクチエボラーグ 癌を治療するための組み合わせ療法
EP4255357A1 (en) 2020-12-29 2023-10-11 Sino Medical Sciences Technology Inc. Drug eluting stent
WO2024089418A1 (en) 2022-10-24 2024-05-02 Cancer Research Technology Limited Tumour sensitisation to checkpoint inhibitors with redox status modifier
WO2024089417A1 (en) 2022-10-24 2024-05-02 Memorial Sloan-Kettering Cancer Center Tumour stratification for responsiveness to an immune checkpoint inhibitor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09511666A (ja) * 1994-04-08 1997-11-25 アトリックス・ラボラトリーズ・インコーポレイテッド 医療装置で使用する付随的ポリマー系
WO1996021427A1 (en) 1995-01-09 1996-07-18 Atrix Laboratories, Inc. Liquid polymer delivery system
UA59384C2 (uk) * 1996-12-20 2003-09-15 Пфайзер, Інк. Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі
ATE203157T1 (de) * 1996-12-20 2001-08-15 Alza Corp Injizierbare depotgelzubereitung und herstellungsverfahren
UA67754C2 (uk) * 1997-10-10 2004-07-15 Пфайзер, Інк. Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти)
US7128927B1 (en) * 1998-04-14 2006-10-31 Qlt Usa, Inc. Emulsions for in-situ delivery systems
US6143314A (en) * 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst

Also Published As

Publication number Publication date
EP1448166A1 (en) 2004-08-25
DOP2002000534A (es) 2003-05-31
GT200200242A (es) 2003-06-25
AP2004003037A0 (en) 2004-06-30
PA8559001A1 (es) 2003-11-12
AU2002347502A1 (en) 2003-06-10
KR20040062977A (ko) 2004-07-09
NO20042273L (no) 2004-07-14
CA2468703A1 (en) 2003-06-05
BR0214610A (pt) 2004-09-14
KR100629380B1 (ko) 2006-09-29
UA76792C2 (uk) 2006-09-15
IL161835A0 (en) 2005-11-20
EA011350B1 (ru) 2009-02-27
AU2009200125A1 (en) 2009-02-05
NZ533115A (en) 2005-12-23
US20090169595A1 (en) 2009-07-02
SV2004001421A (es) 2004-05-07
TNSN04096A1 (fr) 2006-06-01
CN1599598A (zh) 2005-03-23
MXPA04003723A (es) 2005-04-08
US8017144B2 (en) 2011-09-13
WO2003045351A1 (en) 2003-06-05
HUP0402135A3 (en) 2008-04-28
JP4903985B2 (ja) 2012-03-28
CA2468703C (en) 2009-12-29
MA27084A1 (fr) 2004-12-20
EA200400608A1 (ru) 2004-10-28
AU2009200125B2 (en) 2012-02-02
GEP20063951B (en) 2006-10-25
US20030104031A1 (en) 2003-06-05
PL370085A1 (en) 2005-05-16
TW200300695A (en) 2003-06-16
ECSP045124A (es) 2004-07-23
OA12731A (en) 2006-06-28
HUP0402135A2 (hu) 2005-02-28
YU35004A (sh) 2006-08-17
AP1781A (en) 2007-09-27
HRP20040486A2 (en) 2004-10-31
ZA200402755B (en) 2005-04-08
AR037462A1 (es) 2004-11-10
PE20030581A1 (es) 2003-07-08
JP2005515190A (ja) 2005-05-26

Similar Documents

Publication Publication Date Title
IS7217A (is) Leysnistýrðar fjölliðasamsetningar af beinvaxtamótunar efnasamböndum
IS3027B (is) Hraðuppleysandi samsetning af kalsíum viðtaka-virku efnasambandi
DE60124152D1 (de) Kosmetische zusammensetzungen enthaltend siloxancopolymer-netzwerke
DK1417180T3 (da) Fremstilling af aminopyrimidinforbindelser
DK1438306T3 (da) Derivater af UK-2A
DK1351630T3 (da) Implantat til rekonstruktion af led
FI20020772A0 (fi) Kirurginen implantti
IS7007A (is) Kristallaform af asiþrómýsíni
DK1450606T3 (da) Synergistiske sammensætninger til behandling af såsæd
FI20010780A0 (fi) Parannetut koostumukset
DE60315312D1 (de) Arthroplastie-implantat
FI20010694A (fi) Implantti
DK1522539T3 (da) Krystallinsk komposition indeholdende excitalopram
ATE326842T1 (de) Zusammensetzung zur saatgutbehandlung
DK1132570T3 (da) Sammensætninger til syrebehandling af borebrönde
DE60239210D1 (de) Polymer-ton nanoverbundzusammensetzung
DE60100687D1 (de) Netzartige Silikonpolymerzusammensetzungen
DE60230088D1 (de) Prothetisches Implantat
DE60215601D1 (de) Stabile Zusammensetzung
DK1354027T3 (da) Stabilisering af drikkevarer
DE60223455D1 (de) Wasserbeständige Polymernetzwerk-Zusammensetzungen
DE60223962D1 (de) Verwendung Duftstoff zurückhaltender Zusammensetzungen
DK1337228T3 (da) Sammensætninger til fjernelse af human cerumen
DE60239602D1 (de) Dehnbare flüssigkristalline polymerzusammensetzung
DK1597366T3 (da) Modulering af ekspression af insulin-lignende vækstfaktor receptor I